The dozens of ‘devastating, unprecedented and dangerous’ forest fires raging across Sweden are far from manufacturing and industrial centres, says Swedish Association of the Pharmaceutical Industry.
Recipharm has said it will spend SEK5m ($567,000) on a bioanalysis laboratory in Sweden citing the lack of capacity in the Nordic region as a driver for the investment.
Sweden’s pharmaceutical regulator is pushing hard to make water pollution regulations a binding part of GMP, and says “embarrassed” European agencies are dragging their feet more than big pharma.
Pharma companies have called on the Swedish government to prevent manufacturing going the way of R&D and leaving the country, after AstraZeneca closed its research in Lund in 2012.
A UK writer has described how his mission to start a trial for a therapeutic virus against his friend’s cancer has led to a new model of research funding which bypasses sponsors and CROs.
Faced with a raft of consolidation in the market for generic
pharmaceuticals, Germany's Merck KGaA has entered the fray with an
agreement to acquire most of NM Pharma, the Scandinavian generics
business of top drugmaker Pfizer.
Nordic pharmaceutical company Pharmaco forges further into Northern
Europe unveiling new sales activities in Sweden to cut into the
growing generic pharmaceutical market there.
Danish pharmaceutical companies increased their sales to overseas
countries by 20 per cent in the first four months of this year
compared with the same period of 2002, according to Invest In
Denmark.
